Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
about
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropeniaThe Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell TransplantationTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveAntifungal Prophylaxis in Immunocompromised PatientsAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsSystematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsAntifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational sStability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoterPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Sudden death in a patient with bone marrow transplant by a fungus among usFebrile neutropenia in hematologic malignancies.Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation studyVoriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.Population pharmacokinetics of voriconazole in adultsSREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.How I treat mucormycosis.Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patientsInfluence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysPharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell tEfficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.Use of antifungal drugs in hematologyPrimary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection ProphylaxisRisk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.The use of group sequential designs with common competing risks testsPharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part IInfectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.
P2860
Q24200304-E76F068E-D844-4A0A-88B0-65AD69CE33E3Q26740251-B257B08A-B080-49C1-9C18-1E81D5D22884Q27009221-8CF6E7E4-9590-4260-97A3-893B8273F5AAQ28074168-4817331D-3F31-45B6-B31A-3D201257E730Q28080147-DFD50A0B-51A5-45C0-9F4B-AEE2085FEB91Q28083874-3B099FFC-4476-4D75-BCD4-8F359D00BA99Q33559503-6796AF96-BD68-4671-BF5B-9CDED7C92C81Q33605503-1052237A-1D63-40EE-ABA3-28D27C4380FBQ33629045-925E91D6-615E-4375-80E7-E3900A7A777EQ34138276-4FEFA938-685E-4F80-922C-C497757F8877Q34288593-4114296B-6D28-4937-B701-EFFD621F7629Q34315804-6E2AB39E-C5C4-49F5-8EDB-32B8FCB755C8Q34532546-4393D810-4F82-4F28-9F87-6F04FAAB9106Q34572967-21D14885-BC7C-4B92-BC8E-5C9B72B9655BQ34655730-98FC0D4C-A543-4CD0-AC84-2FEE7D6E7CAEQ34667166-8CC3A1CE-A626-43B5-9138-3303EE58F969Q35168889-BF554234-ECFF-41BA-BF3C-8664CAEC7884Q35659502-8601795D-8BDA-452D-BFF3-E055E8D256B8Q35666490-289D2FC6-E785-44D1-8F71-134BD7DC5B1AQ35666510-266501CC-B7D4-413B-AEEB-84F7CF137764Q35672258-12938559-D660-4A5B-B8A8-8F14E9F86793Q35756513-2DF7DC43-9B44-46C6-9820-2933695BF7C2Q35797637-A3525F09-2C79-4065-8225-ADA91A353FA1Q35807013-D5C037FD-0B5E-48B9-B6E7-1A40367A6140Q35821259-F82CB75E-A3BA-4D18-8097-FA33DC313553Q35848794-3A668B13-96B5-46DA-941E-2CB05A3014D3Q35949528-DE19054A-5205-49F2-A390-0118585CC45EQ35959476-9A2124F1-D4DE-4CEB-8CC8-15610CB0BA5BQ35959480-19E0FBE8-F851-4AF5-9BB5-196DEB8368ECQ36212392-D1DA919D-09CE-425D-9065-DAAB967D1A8EQ36225173-30A06929-4B19-4ED0-9488-96A6DE6DDECBQ36236659-24E1A3B2-D957-4E1E-BD71-CBC18F4461CCQ36364856-8E081F9B-38DB-4469-A6F3-BD3746E50C13Q36406975-1A8A26A1-8AA9-419D-914A-E3588048D02BQ36439034-5C4CDD68-5E37-454C-B3F3-04DC17C70697Q36540732-4A95D53F-4BD5-402B-B348-F63593929FE6Q36614806-CAFC2A87-B8F9-477E-8744-628839576013Q36777599-3D60D576-5995-49F4-9A97-191AC78190FFQ37150434-A2E337AA-B9E9-41C0-ACC8-D829612F53CEQ37220447-F726CCFE-93F9-417C-A546-8950B198FFD4
P2860
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Randomized, double-blind trial ...... opoietic cell transplantation.
@ast
Randomized, double-blind trial ...... opoietic cell transplantation.
@en
Randomized, double-blind trial ...... opoietic cell transplantation.
@nl
type
label
Randomized, double-blind trial ...... opoietic cell transplantation.
@ast
Randomized, double-blind trial ...... opoietic cell transplantation.
@en
Randomized, double-blind trial ...... opoietic cell transplantation.
@nl
prefLabel
Randomized, double-blind trial ...... opoietic cell transplantation.
@ast
Randomized, double-blind trial ...... opoietic cell transplantation.
@en
Randomized, double-blind trial ...... opoietic cell transplantation.
@nl
P2093
P2860
P1433
P1476
Randomized, double-blind trial ...... opoietic cell transplantation.
@en
P2093
Adam M Mendizabal
Blood and Marrow Transplant Clinical Trials Network
Dennis L Confer
Edward A Stadtmauer
Helen L Leather
Iris D Gersten
Janice Brown
Javier Bolaños-Meade
Joanne Kurtzberg
John F Dipersio
P2860
P304
P356
10.1182/BLOOD-2010-02-268151
P407
P577
2010-09-08T00:00:00Z